Functional assessment and specific depletion of alloreactive human T cells using flow cytometry
- 1 December 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (12) , 3429-3436
- https://doi.org/10.1182/blood-2004-05-1918
Abstract
Human T-cell alloreactivity plays an important role in many disease processes, including the rejection of solid organ grafts and graft-versus-host disease (GVHD) following allogeneic stem cell transplantation. To develop a better understanding of the T cells involved in alloreactivity in humans, we developed a cytokine flow cytometry (CFC) assay that enabled us to characterize the phenotypic and functional characteristic of T cells responding to allogeneic stimuli. Using this approach, we determined that most T-cell alloreactivity resided within the CD4+ T-cell subset, as assessed by activation marker expression and the production of effector cytokines (eg, tumor necrosis factor α [TNF]α) implicated in human GVHD. Following prolonged stimulation in vitro using either allogeneic stimulator cells or viral antigens, we found that coexpression of activation markers within the CD4+ T-cell subset occurred exclusively within a subpopulation of T cells that significantly increased their surface expression of CD4. We then developed a simple sorting strategy that exploited these phenotypic characteristics to specifically deplete alloreactive T cells while retaining broad specificity for other stimuli, including viral antigens and third-party alloantigens. This approach also was applied to specifically enrich or deplete human virus-specific T cells.Keywords
This publication has 30 references indexed in Scilit:
- Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulationBlood, 2004
- Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesBlood, 2003
- Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppressionBlood, 2002
- P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cellsBlood, 2002
- SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI-INTERLEUKIN-2 RECEPTOR B CHAIN-SPECIFIC IMMUNOTOXINTransplantation, 1990
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLSThe Lancet, 1981
- Differential function of major histocompatibility complex antigens in T-lymphocyte activationNature, 1976